First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG

Analysis of this real-world cohort of patients with metastatic melanoma showed a trend towards poorer survival outcomes upon first-line treatment with CPI in ALM compared to cutaneous melanoma of other subtypes.

Authors

Institutions

Publication Details

Journal
European Journal of Cancer
Published
2025-03-15
DOI
https://doi.org/10.1016/j.ejca.2025.115356
Citations
3
Primary Topic
Cutaneous Melanoma Detection and Management
Type
article
Field-Weighted Citation Impact
3.14

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG

Sören Reinhard, Carsten Weishaupt, Berenice M. Lang, Harm-Henning Lindhof et al.
3 citations
European Journal of Cancer
Cutaneous Melanoma Detection and Management
3.14
article

First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG

Sören Reinhard, Carsten Weishaupt, Berenice M. Lang, Harm-Henning Lindhof, Kai Christian Klespe, Annekathrin Silvia Nedwed, Jochen Sven Utikal, Edgar Dippel, Rudolf Alexander Herbst, Ralf Gutzmer, Christoffer Gebhardt, Anja Gesierich, Yenny Angela, Michael Weichenthal, Maria Isabel Fleischer, Claudia Pföhler, Sebastian Haferkamp, Andrea Forschner, Katharina C. Kähler, Dirk Schadendorf, Friedegund Meier, Cord Sunderkötter, Georg Christian Lodde, Stephan Grabbe, Julia Welzel, Christiane Michl, Henner Stege, Carola Berking, Selma Ugurel, Frank Meiß, Saskia Wenk, Cornelia Mauch, Anca Sindrilaru, Anne Zaremba, Jessica Cecile Hassel, Maximilian Haist, Gaston Schley, Markus V. Heppt, Carmen Loquai, Alexander Kreuter, Ulrike Leiter, Beatrice Schell, Martin Kaatz, Lucie Heinzerling, Michael Sachse, Peter Mohr, Jens Ulrich, Imke von Wasielewski
article en
3 citations

Abstract

Analysis of this real-world cohort of patients with metastatic melanoma showed a trend towards poorer survival outcomes upon first-line treatment with CPI in ALM compared to cutaneous melanoma of other subtypes.

European Journal of CancerVol. 220
Goethe University Frankfurt (DE), Universität Hamburg (DE), University of Freiburg (DE), German Cancer Research Center (DE), Johannes Gutenberg University Mainz (DE), Heidelberg University (DE), Hohenstein Institute (DE), University Medical Center Freiburg (DE), University Hospital Augsburg (DE), University Hospital Heidelberg (DE), University Hospital Regensburg (DE), Medizinische Hochschule Hannover (DE), Düsseldorf University Hospital (DE), University Medical Center of the Johannes Gutenberg University Mainz (DE), SRH Wald-Klinikum Gera (DE), Klinikum Darmstadt (DE), Helios Hospital Schwerin (DE), University Hospital Münster (DE), University Medical Center Hamburg-Eppendorf (DE), National Center for Tumor Diseases (DE), University Hospital Schleswig-Holstein (DE), Essen University Hospital (DE), HELIOS St. Elisabeth Klinik Oberhausen (DE), Universitätsklinikum Würzburg (DE), Klinikum Ludwigshafen (DE), Elbe Kliniken Stade-Buxtehude (DE), Klinikum Bremerhaven-Reinkenheide (DE), Helios Klinikum Erfurt (DE), Comprehensive Cancer Center Erlangen (DE), Klinikum Bremen-Mitte (DE), University Hospital Ulm (DE), University Medical Centre Mannheim (DE), University Hospital Carl Gustav Carus (DE), Johannes Wesling Klinikum Minden (DE), Heinrich Heine University Düsseldorf (DE), Martin Luther University Halle-Wittenberg (DE), University of Tübingen (DE), Ludwig-Maximilians-Universität München (DE), Ruhr University Bochum (DE), Saarland University (DE), University of Lübeck (DE)
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Sanofi, Regeneron Pharmaceuticals, Les Laboratories Pierre Fabre, Recordati Rare Diseases, Galderma, Sun Pharma, InflaRx, LEO Pharma, Sanofi Genzyme
Good health and well-being
Openalex Percentile: Top 9%
Cutaneous Melanoma Detection and Management
3.14
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.